The general concepts of an equivalence trial, applied to ASSENT-2, a large-scale mortality study comparing two fibrinolytic agents in acute myocardial infarction
Eur Heart J
.
2001 Jun;22(11):898-902.
doi: 10.1053/euhj.2000.2323.
Authors
E Lesaffre
1
,
E Bluhmki
,
F Wang-Clow
,
S Berioli
,
T Danays
,
N L Fox
,
F Van de Werf
Affiliation
1
Biostatistical Centre, University of Leuven, Belgium.
PMID:
11428813
DOI:
10.1053/euhj.2000.2323
No abstract available
Publication types
Clinical Trial
MeSH terms
Confidence Intervals
Fibrinolytic Agents / pharmacokinetics*
Humans
Myocardial Infarction / drug therapy*
Myocardial Infarction / mortality*
Therapeutic Equivalency
Substances
Fibrinolytic Agents